Treatment Response and Outcomes of Prostate Cancer Patients Carrying the Germline MMS22L F722fs Mutation. Kanayama M, Daniels VA, Gielzak M, Brame A, et al. Prostate 2026 Jan 22. doi: 10.1002/pros.70133.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kanayama M, Daniels VA, Gielzak M, Brame A, et al. Treatment Response and Outcomes of Prostate Cancer Patients Carrying the Germline MMS22L F722fs Mutation. Prostate 2026 Jan 22. doi: 10.1002/pros.70133.
PMID: 41570124